Elisabeth Rosenthal Urges FDA to Regulate 'Dancing, Biking, Singing Patients' Claims Amid Mixed Reactions and Stricter PCAOB Enforcement

Elisabeth Rosenthal has called for the FDA to enhance its efforts in regulating misleading claims related to health treatments, as highlighted in her recent op-ed. The piece has garnered mixed reactions, with some experts, including Alec Gaffney, expressing concern over inaccuracies in her portrayal of FDA regulations regarding drug advertisements. Meanwhile, in a related development, the SEC has approved stricter enforcement measures by the PCAOB, which will increase scrutiny on accounting firms, reflecting a growing demand for accountability in financial practices.